Back

Safety and feasibility concerns of radiotherapy in the presence of subcutaneous implantable cardioverter-defibrillator

9 April 2024 (11:30 - 12:15)
Organised by: Logo
Congress Presentation Part of: Ventricular tachycardia 4 Radiotherapy EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Associate Professor Mateusz Tajstra

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)

8 More presentations in this session

Presentation thumbnail
Cryoablation of ventricular tachycardia using ultra-low temperature technology: acute success and insights from the post-interventional CMR
Associate Professor B. Dinov (Giessen, DE)
Abstract Slides Video
Presentation thumbnail
Cardiac tumors with life threatening arrhythmia, an eight year single centre experience
Doctor O. Kamel (Aswan, EG)
Abstract Slides Video
Presentation thumbnail
Coronary venous ethanol ablation of refractory left ventricular summit arrhythmias: comparison with radiofrequency ablation
Doctor M. De Smet (Brugge, BE)
Abstract Slides Video
Presentation thumbnail
THerapy Efficacy in Short or long-coupled idiopathic ventricular fibrillation: an International Survey (THESIS)
Doctor O. Tovia Brodie (Jerusalem, IL)
Abstract Slides Video
Presentation thumbnail
Initial experience with ablation of ventricular arrhythmias using a pulsed-field system
Doctor P. Stojadinovic (Prague, CZ)
Abstract Slides Video

Access the full session

Session thumbnail
Ventricular tachycardia 4

The Event

Event poster

EHRA 2024

9 April 2024 11:30 CET
You may be interested in
thumbnail
Congress Presentation
The acute changes in parameters of cardiac implantable electronic devices in patients undergoing radiation therapy
31 March 2025
thumbnail
Congress Presentation
Extravascular defibrillator in patients not suited for the subcutaneous defibrillator.
1 September 2025
thumbnail
Congress Presentation
Stereotactic radiotherapy: clinical data
16 April 2023
thumbnail
Congress Presentation
Safety of stereotactic body radiation therapy in the presence of leadless Aveir pacemaker in the in vitro model
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources